Invivyd Correlations
| IVVD Stock | USD 0.81 0.01 1.25% |
The current 90-days correlation between Invivyd and Adverum Biotechnologies is 0.13 (i.e., Average diversification). The correlation of Invivyd is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Invivyd Correlation With Market
Very weak diversification
The correlation between Invivyd and DJI is 0.52 (i.e., Very weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Invivyd and DJI in the same portfolio, assuming nothing else is changed.
Moving against Invivyd Stock
| 0.4 | MRK | Merck Company Earnings Call This Week | PairCorr |
Related Correlations Analysis
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Invivyd Stock performing well and Invivyd Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Invivyd's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| PASG | 6.30 | (0.35) | (0.01) | 0.06 | 6.94 | 15.95 | 40.89 | |||
| ABSI | 2.90 | (0.04) | 0.00 | 0.20 | 3.16 | 6.69 | 15.53 | |||
| ADVM | 4.70 | (0.52) | (0.03) | 0.02 | 5.67 | 12.15 | 30.23 | |||
| KZR | 2.65 | (0.23) | 0.00 | (0.04) | 0.00 | 4.59 | 16.72 | |||
| GLUE | 3.03 | (0.04) | 0.01 | 0.21 | 3.73 | 7.27 | 18.03 | |||
| PRAX | 2.42 | 0.52 | 0.19 | 0.64 | 2.36 | 6.29 | 15.46 | |||
| ERAS | 3.89 | 0.19 | 0.05 | 0.37 | 4.90 | 7.09 | 40.51 | |||
| CADL | 3.65 | 0.18 | 0.11 | 0.32 | 3.43 | 8.83 | 21.75 |
Invivyd Corporate Management
| Laura Walker | CoFounder Officer | Profile | |
| Elham PharmD | Chief Officer | Profile | |
| Peter MD | Chief Officer | Profile | |
| Robert Allen | Chief Officer | Profile | |
| Jill JD | Chief Secretary | Profile | |
| Mark Wingertzahn | Senior Affairs | Profile | |
| Timothy Lee | Chief Officer | Profile |